Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Larsimont

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
The American Journal of Pathology|November 14, 2000
Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samplesM Tanner, D Gancberg, A Di Leo, et al.
British Journal of Cancer|May 13, 2015
Revisiting the transcriptional analysis of primary tumours and associated nodal metastases with enhanced biological and statistical controls: application to thyroid cancerM Tarabichi, M Saiselet, C Trésallet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2007
HER-2 overexpression/amplification and its interaction with taxane-based therapy in breast cancerE Azambuja, V Durbecq, D D Rosa, et al.
Analytical and Quantitative Cytology and Histology|June 1, 1991
Comparison of fine needle aspirates of breast cancers to imprint smears by means of digital cell image analysisI Salmon, M Coibion, D Larsimont, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 1997
Tumor type and vascularity: important variables in infusional brachytherapy with colloidal 32PH Nguyen, G Ghanem, R Morandini, et al.
Cancer|June 1, 1989
Correlation between nuclear cytomorphometric parameters and estrogen receptor levels in breast cancerD Larsimont, R Kiss, D d'Olne, et al.
Histopathology|December 19, 2000
Trisomy 6 in Merkel cell carcinoma: a recurrent chromosomal aberrationD Gancberg, F Feoli, J Hamels, et al.
Gynecologic Oncology|February 27, 2004
Rates of topoisomerase II-alpha and HER-2 gene amplification and expression in epithelial ovarian carcinomaM S Mano, A Awada, A Di Leo, et al.
Analytical and Quantitative Cytology and Histology|December 1, 1989
Relationship between computerized morphonuclear image analysis and histopathologic grading of breast cancerD Larsimont, R Kiss, D d'Olne, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1994
[Plexiform fibrohistiocytic tumor]U Sass, J André, J C Noël, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
The American Journal of Pathology|November 14, 2000
Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samplesM Tanner, D Gancberg, A Di Leo, et al.
British Journal of Cancer|May 13, 2015
Revisiting the transcriptional analysis of primary tumours and associated nodal metastases with enhanced biological and statistical controls: application to thyroid cancerM Tarabichi, M Saiselet, C Trésallet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2007
HER-2 overexpression/amplification and its interaction with taxane-based therapy in breast cancerE Azambuja, V Durbecq, D D Rosa, et al.
Analytical and Quantitative Cytology and Histology|June 1, 1991
Comparison of fine needle aspirates of breast cancers to imprint smears by means of digital cell image analysisI Salmon, M Coibion, D Larsimont, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 1997
Tumor type and vascularity: important variables in infusional brachytherapy with colloidal 32PH Nguyen, G Ghanem, R Morandini, et al.
Cancer|June 1, 1989
Correlation between nuclear cytomorphometric parameters and estrogen receptor levels in breast cancerD Larsimont, R Kiss, D d'Olne, et al.
Histopathology|December 19, 2000
Trisomy 6 in Merkel cell carcinoma: a recurrent chromosomal aberrationD Gancberg, F Feoli, J Hamels, et al.
Gynecologic Oncology|February 27, 2004
Rates of topoisomerase II-alpha and HER-2 gene amplification and expression in epithelial ovarian carcinomaM S Mano, A Awada, A Di Leo, et al.
Analytical and Quantitative Cytology and Histology|December 1, 1989
Relationship between computerized morphonuclear image analysis and histopathologic grading of breast cancerD Larsimont, R Kiss, D d'Olne, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1994
[Plexiform fibrohistiocytic tumor]U Sass, J André, J C Noël, et al.
Pageof 10